Page last updated: 2024-11-06

prednisolone and Benign Mastocytoma

prednisolone has been researched along with Benign Mastocytoma in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Prednisolone treatment that caused a marked reduction in tumour volume was correlated with reduced pSTAT3 expression."1.38Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment. ( Chang, SC; Chiu, CY; Hsu, WL; Teng, SP; Wong, ML, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teng, SP1
Hsu, WL1
Chiu, CY1
Wong, ML1
Chang, SC1

Other Studies

1 other study available for prednisolone and Benign Mastocytoma

ArticleYear
Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment.
    Veterinary journal (London, England : 1997), 2012, Volume: 193, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dog Diseases; Dogs; Female; Glucoc

2012